Is Zelnorm® on Its Way Back to Market?
Novartis , the pharmaceutical company that produces Zelnorm®, is now allowed to distribute the drug on a limited basis for treatment of IBS .. Last spring, Zelnorm® was taken off the market after a few cardiovascular events (stroke and heart attack) in patients taking the drug. The withdrawal of Zelnorm® limited the treatment options of patients with constipation dominant IBS. The current use of the medicine is restricted to only a limited group of patients, women under the age of 55, which fit the criteria set by the FDA. Pioneer Press